User:Mr. Ibrahem/Somapacitan

Somapacitan, sold under the brand name Sogroya, is a medication used to treat growth hormone deficiency in adults. It is given by injection under the skin.

Common side effects include back pain, joint paint, indigestion, sleep problems, dizziness, tonsillitis, swelling of the arms or legs, vomiting, adrenal insufficiency, high blood pressure, weight gain, and low red blood cells. Other side effects may include cancer, diabetes, intracranial hypertension, allergic reactions, hypoadrenalism, and pancreatitis. Use appears to be safe in pregnancy. It is a human growth hormone analog.

Somapacitan was approved for medical use in the United States in 2020 and Europe and the United Kingdom in 2021. It is produced in Escherichia coli by recombinant DNA technology.